1SXP vs NNNN: Side-by-Side Comparison
Compare SCHOTT Pharma AG & Co. KGaA (1SXP) and Anbio Biotechnology - Class A (NNNN) side by side: market cap EUR 2.58B vs USD 557.42M. Financials, growth and model signals on Bullrun.
| Metric | 1SXP | NNNN |
|---|---|---|
| Company | SCHOTT Pharma AG & Co. KGaA | Anbio Biotechnology - Class A |
| Country / Exchange | Germany · XETRA | Germany · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Medical Instruments & Supplies | Medical Instruments & Supplies |
| Market cap | EUR 2.58B | USD 557.42M |
| P/E ratio | 18.0 | — |
| Dividend yield | 1.04% | — |
| Valuation model | 29.0% undervalued | — |
| Revenue (latest FY) | — | USD 8.65M |
| Revenue growth YoY | — | +5.6% |
| Net income | — | USD 6.40M |
| Gross margin | — | 87.2% |
| Diluted EPS | — | 0.15 |